Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 14, 2016 8:08 AM ET

Biotechnology

Company Overview of AnaptysBio, Inc.

Key Executives for AnaptysBio, Inc.

NameBoard RelationshipsTitleAge
Hamza Suria M.Sc., MBA10 RelationshipsChief Executive Officer, President and Director39
Andrew B. Cubitt Ph.D.No RelationshipsCo-Founder52
Robert E. Hoffman CPA34 RelationshipsChief Financial Officer49
Margaret Marino No RelationshipsHead of Project Management--

AnaptysBio, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
James N. Topper M.D., Ph.D. 64 RelationshipsFrazier Healthcare Partners53
Hamza Suria M.Sc., MBA 10 RelationshipsAnaptysBio, Inc.39
Carol G. Gallagher Pharm.D 59 RelationshipsNew Enterprise Associates50
Hollings C. Renton III., M.B.A 36 RelationshipsPortola Pharmaceuticals, Inc.68
John P. Schmid 16 RelationshipsAuspex Pharmaceuticals, Inc.52
View All Board Members

AnaptysBio, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee John P. Schmid16 Relationships3 Executives
Compensation Committee Pharm.DCarol G. Gallagher59 Relationships2 Executives
Nominating Committee III., M.B.AHollings C. Renton36 Relationships3 Executives
Corporate Governance Committee III., M.B.AHollings C. Renton36 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$382.1K
382.1K
327.5K
Bonus
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$382.1K
382.1K
14.9M
Compensation as of Fiscal Year 2015
AnaptysBio, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Wausau Paper Corp. Announces Management Changes
January 22, 2016 8:10 PM ET
Spectrum Brands Holdings, Inc. Appoints David M. Maura as Executive Chairman
January 21, 2016 11:30 AM ET
Peter Harf Intends to Step Down from the Board of Reckitt Benckiser Group plc
December 21, 2015 7:00 AM ET
Blue Power Group Limited Appoints Catherine K. Goodall as Director to the Board
December 05, 2015 12:00 AM ET
Procter & Gamble Co. Announces Executive Changes
November 20, 2015 11:57 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact AnaptysBio, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.